Found: 64
Select item for more details and to access through your institution.
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors.
- Published in:
- BioDrugs, 2024, v. 38, n. 5, p. 611, doi. 10.1007/s40259-024-00669-y
- By:
- Publication type:
- Article
Interleukin-1β und pro-tumorale Inflammation – Zentrale Faktoren bei der Entstehung von Krebserkrankungen.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, p. 6, doi. 10.1159/000510547
- By:
- Publication type:
- Article
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3390, doi. 10.3390/cells10123390
- By:
- Publication type:
- Article
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 472, doi. 10.3390/cells8050472
- By:
- Publication type:
- Article
CXCR6 expressing T cells: Functions and role in the control of tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1022136
- By:
- Publication type:
- Article
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.903562
- By:
- Publication type:
- Article
CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.883694
- By:
- Publication type:
- Article
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.845499
- By:
- Publication type:
- Article
P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2019, v. 32, n. 5, p. 207, doi. 10.1093/protein/gzz027
- By:
- Publication type:
- Article
TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2016, v. 29, n. 10, p. 467, doi. 10.1093/protein/gzw037
- By:
- Publication type:
- Article
FLT3 - ITD positive acute lymphocytic leukemia, does it impact on disease's course?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Migratory Engineering of T Cells for Cancer Therapy.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1845, doi. 10.3390/vaccines10111845
- By:
- Publication type:
- Article
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 1, p. 227, doi. 10.1007/s13402-022-00747-9
- By:
- Publication type:
- Article
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 611, p. 1, doi. 10.1126/scitranslmed.abc8188
- By:
- Publication type:
- Article
Isolated Limb Perfusion with Melphalan for the Treatment of Intractable Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
- Published in:
- Acta Haematologica, 2010, v. 123, n. 3, p. 179, doi. 10.1159/000294963
- By:
- Publication type:
- Article
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1283, doi. 10.3390/ijms20061283
- By:
- Publication type:
- Article
PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01955
- By:
- Publication type:
- Article
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 94, doi. 10.3390/curroncol29010008
- By:
- Publication type:
- Article
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 4, p. 696, doi. 10.1038/s41416-023-02332-9
- By:
- Publication type:
- Article
ESCRT machinery: role of membrane repair mechanisms in escaping cell death.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01108-6
- By:
- Publication type:
- Article
7 Fragen an Prof. Dr. med. Sebastian Kobold, Leiter der AG Immunpharmakologie an der Klinik der LMU München.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 3, p. 152, doi. 10.1159/000518701
- By:
- Publication type:
- Article
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv146
- By:
- Publication type:
- Article
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of a New Fusion Receptor on PD-1--Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv146
- By:
- Publication type:
- Article
Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju364
- By:
- Publication type:
- Article
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case report.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 391, doi. 10.1007/s00432-019-03061-4
- By:
- Publication type:
- Article
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1242, doi. 10.1634/theoncologist.2009-0109
- By:
- Publication type:
- Article
Immunotherapy in Tumors.
- Published in:
- Deutsches Ärzteblatt International, 2015, v. 112, n. 48, p. 809, doi. 10.3238/arztebl.2015.0809
- By:
- Publication type:
- Article
Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 218, doi. 10.1007/s11899-021-00628-2
- By:
- Publication type:
- Article
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment.
- Published in:
- Seminars in Immunopathology, 2023, v. 45, n. 2, p. 215, doi. 10.1007/s00281-022-00962-4
- By:
- Publication type:
- Article
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies.
- Published in:
- Biological Chemistry, 2022, v. 403, n. 5/6, p. 495, doi. 10.1515/hsz-2021-0401
- By:
- Publication type:
- Article
Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/134081
- By:
- Publication type:
- Article
Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation.
- Published in:
- Clinical & Developmental Immunology, 2011, p. 1, doi. 10.1155/2011/302145
- By:
- Publication type:
- Article
Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies.
- Published in:
- Clinical & Developmental Immunology, 2010, p. 1, doi. 10.1155/2010/721531
- By:
- Publication type:
- Article
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03688-4
- By:
- Publication type:
- Article
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4195, doi. 10.1007/s00262-023-03556-7
- By:
- Publication type:
- Article
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2499, doi. 10.1007/s00262-023-03439-x
- By:
- Publication type:
- Article
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 11, p. 1151, doi. 10.1007/s00262-014-1588-x
- By:
- Publication type:
- Article
An In Vivo Inflammatory Loop Potentiates KRAS Blockade.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 592, doi. 10.3390/biomedicines10030592
- By:
- Publication type:
- Article
Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 307, doi. 10.3390/biomedicines10020307
- By:
- Publication type:
- Article
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1275828
- By:
- Publication type:
- Article
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16838-w
- By:
- Publication type:
- Article
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2608, doi. 10.3390/cancers16142608
- By:
- Publication type:
- Article
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1650, doi. 10.3390/cancers15061650
- By:
- Publication type:
- Article
Therapeutic Strategies for Targeting IL-1 in Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 477, doi. 10.3390/cancers13030477
- By:
- Publication type:
- Article
Challenges in Clinical Trial Design for T Cell‐Based Cancer Immunotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 47, doi. 10.1002/cpt.1659
- By:
- Publication type:
- Article